يعرض 1 - 10 نتائج من 11 نتيجة بحث عن '"DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::tratamientos basados en células y tejidos"', وقت الاستعلام: 1.61s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, León-Román J, Bermejo S, Bolufer M, Bestard O, Soler MJ Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CSUR National Unit of Expertise for Complex Glomerular Diseases of Spain, Barcelona, Spain. Iacoboni G Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Carpio C, Sánchez-Salinas M, Barba P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. García-Carro C Nephrology Department, San Carlos Clinical University Hospital, Madrid, Spain. Alonso-Martínez C Servei de Farmàcia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Clinical Kidney Journal;17(3); https://doi.org/10.1093/ckj/sfae027Test; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI21%2F01292; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/AC22%2F00029; info:eu-repo/grantAgreement/ES/PEICTI2021-2023/RD21%2F0005%2F0016; León-Román J, Iacoboni G, Bermejo S, Carpio C, Bolufer M, García-Carro C, et al. Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies. Clin Kidney J. 2024 Mar;17(3):27.; https://hdl.handle.net/11351/11224Test

  2. 2
    دورية أكاديمية

    المؤلفون: Sánchez-Celma, Mónica

    المساهمون: Servei de Farmàcia, Hospital Sant Joan de Déu, Barcelona, Spain, Departament de Salut

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Butlletí de Prevenció d'Errors de Medicació de Catalunya;21(4); Sánchez Celma M. Errors de medicació i altres riscos relacionats amb l’ús de teràpies avançades. Butll Prev Errors Medicació Catalunya. 2023 oct.-des.;21(4).; https://hdl.handle.net/11351/11309Test

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Delgadillo J Banc de Sang i Teixits (BST), Edifici Dr. Frederic Duran i Jordà, Barcelona, Spain. Grup de Recerca de Medicina Transfusional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Kerkelä E Irish Blood Transfusion Service, National Blood Centre, Dublin, Ireland. Waters A Irish Blood Transfusion Service, National Blood Centre, Dublin, Ireland. van den Akker E Department of Hematopoiesis and Sanquin Research, Landsteiner Laboratory, Department of Molecular Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Lechanteur C, Baudoux E University of Liège, Laboratory of Cell and Gene Therapy LTCG, Liège, Belgium. Vives J Banc de Sang i Teixits (BST), Edifici Dr. Frederic Duran i Jordà, Barcelona, Spain. Grup de Recerca d’Enginyeria Tissular Musculoesquelètica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cytotherapy;25(12); https://doi.org/10.1016/j.jcyt.2023.08.001Test; Delgadillo J, Kerkelä E, Waters A, van den Akker E, Lechanteur C, Baudoux E, et al. A management model in blood, tissue and cell establishments to ensure rapid and sustainable patient access to advanced therapy medicinal products in Europe. Cytotherapy. 2023 Dec;25(12):1259–64.; https://hdl.handle.net/11351/10661Test

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Vives J Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Teràpia Cellular, Banc de Sang i Teixits (BST), Edifici Dr. Frederic Duran i Jordà, Barcelona, Spain. Grup de Recerca d’Enginyeria Tissular Musculoesquelètica, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Spanish Advanced Therapy Network (RICORS TERAV), Instituto de Salud Carlos III ((ISCIII), Madrid, Spain. Sánchez-Guijo F Spanish Advanced Therapy Network (RICORS TERAV), Instituto de Salud Carlos III ((ISCIII), Madrid, Spain. Department of Medicine, University of Salamanca, Salamanca, Spain. Cell Therapy Area & Haematology Department, Instituto de Investigación Biomédica de Salamanca, University Hospital of Salamanca, Salamanca, Spain. Gnecchi M Cell Therapy Area & Haematology Department, Instituto de Investigación Biomédica de Salamanca, University Hospital of Salamanca, Salamanca, Spain. Department of Molecular Medicine, Unit of Cardiology, University of Pavia, Pavia, Italy. Department of Cardiothoracic and Vascular Sciences, Translational Cardiology Unit, Fondazione IRCCS, Policlinico San Matteo, Pavia, Italy. Zwaginga JJ Department of Hematology, LUMC, Leiden, the Netherlands, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.spreadsheetml.sheet

    العلاقة: Cytotherapy;25(10); https://doi.org/10.1016/j.jcyt.2023.06.006Test; Vives J, Sánchez-Guijo F, Gnecchi M, Zwaginga JJ. Cell and gene therapy workforce development: the role of the International Society for Cell & Gene Therapy (ISCT) in the creation of a sustainable and skilled workforce in Europe. Cytotherapy. 2023 Oct;25(10):1033–6.; https://hdl.handle.net/11351/10397Test

  5. 5
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Reina-Ortiz C, Mozas MP, Anel A Apoptosis, Immunity and Cancer Group, Department Biochemistry and Molecular and Cell Biology, Aragón Health Research Institute (IIS-Aragón), University of Zaragoza, Zaragoza, Spain. Ovelleiro D Unitat de Trastorns Neuromusculars, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Gao F Institute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, CNRS, University Hospital Center Montpellier, Montpellier, France. Immuno-Oncology Laboratory, School of Basic Medicine, Central South University, Changsha, China. Villalba M Institute of Regenerative Medicine and Biotherapy, University of Montpellier, INSERM, CNRS, University Hospital Center Montpellier, Montpellier, France, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: International Journal of Molecular Sciences;24(17); https://doi.org/10.3390/ijms241713556Test; Reina-Ortiz C, Mozas MP, Ovelleiro D, Gao F, Villalba M, Anel A. Dynamic Changes in miRNA Expression during the Generation of Expanded and Activated NK Cells. Int J Mol Sci. 2023 Aug 31;24(17):13556.; https://hdl.handle.net/11351/10305Test; 001061159900001

  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, López-Chicón P, Castells-Sala C, Piteira AR, Fariñas O, Tabera J Barcelona Tissue Bank (BTB), Banc de Sang i Teixits (BST), Barcelona, Spain. Biomedical Research Institute (IIB-Sant Pau, SGR1113), Barcelona, Spain. Pérez ML, Vilarrodona A Barcelona Tissue Bank (BTB), Banc de Sang i Teixits (BST), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Therapeutics and Clinical Risk Management;19; https://doi.org/10.2147/TCRM.S410574Test; info:eu-repo/grantAgreement/EC/H2020/709567; López-Chicón P, Pérez ML, Castells-Sala C, Piteria RA, Fariñas O, Tabera J, et al. Quality by Design: Development of Safe and Efficacious Full-Thickness Acellular Dermal Matrix Based on EuroGTPII Methodologies. Ther Clin Risk Manag. 2023 Jul 4;19:567–78.; https://hdl.handle.net/11351/10116Test; 001025680800001

  7. 7
    تقرير

    المساهمون: Departament de Salut

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Hub de teràpies avançades i emergents de Catalunya: pla d’acció. Barcelona: Departament de Salut; 2023.; https://hdl.handle.net/11351/10690Test

  8. 8
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Vives J Banc de Sang i Teixits, Edifici Dr. Frederic Duran i Jordà, Barcelona, Spain. Grup de Recerca en Enginyeria Tissular Musculoesquelètica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Sòria MG Banc de Sang i Teixits, Barcelona, Spain. McGrath E International Council for Commonality in Blood Banking Automation (ICCBBA), San Bernardino, USA. Magri M ASST Papa Giovanni XXIII, Bergamo, Italy, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cells;11(13); https://doi.org/10.3390/cells11132112Test; info:eu-repo/grantAgreement/ES/PE2017-2020/RD21%2F0017%2F0022; info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01788; Vives J, Sòria MG, McGrath E, Magri M. The Quality Management Ecosystem in Cell Therapy in Catalonia (Spain): An Opportunity for Integrating Standards and Streamlining Quality Compliance. Cells. 2022 Jul 5;11(13):2112.; https://hdl.handle.net/11351/8189Test; 000825484600001

  9. 9
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Custodia A, Ouro A, Aramburu-Núñez M, Pías-Peleteiro JM NeuroAging Laboratory (NEURAL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. Sargento-Freitas J Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal. Centro Neurociências e Biologia Celular, Coimbra, Portugal. Hervella P Neuroimaging and Biotechnology Laboratory (NOBEL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain. Rosell A Laboratori de Recerca Neurovascular, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Neurology;13; https://doi.org/10.3389/fneur.2022.940682Test; info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00186; info:eu-repo/grantAgreement/ES/PE2017-2020/RD21%2F0006%2F0007; Custodia A, Ouro A, Sargento-Freitas J, Aramburu-Núñez M, Pías-Peleteiro JM, Hervella P, et al. Unraveling the potential of endothelial progenitor cells as a treatment following ischemic stroke. Front Neurol. 2022 Sep 8;13:940682.; https://hdl.handle.net/11351/8684Test; 000856244100001

  10. 10
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Bastos-Oreiro M Hospita Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. Gutierrez A Hospital Universitario Son Espases, Fundació Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma de Mallorca, Spain. Reguera JL Hematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain. Iacoboni G, Abrisqueta P, Barba P Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. López-Corral L Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IDBAL), CIBERONC, Salamanca, Spain. Terol MJ Hematology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Immunology;13; https://doi.org/10.3389/fimmu.2022.855730Test; Bastos-Oreiro M, Gutierrez A, Reguera JL, Iacoboni G, López-Corral L, Terol MJ, et al. Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups. Front Immunol. 2022 Jul 12;13:3148.; https://hdl.handle.net/11351/9555Test; 000834262500001